Psilocybin trial shows six months of depression relief from one dose

One or two doses of psilocybin provided six months of relief from depression that nothing else could touch, in two late-stage clinical trials of Comp360. British biotech Compass Pathways announced the findings on February 17th, according to The Economist. David Erritzoe at Imperial College called it "very good news for psychedelic therapies." — Read the rest The post Psilocybin trial shows six months of depression relief from one dose appeared first on Boing Boing.